Literature DB >> 25332123

CFP-10 from Mycobacterium tuberculosis selectively activates human neutrophils through a pertussis toxin-sensitive chemotactic receptor.

Amanda Welin1, Halla Björnsdottir2, Malene Winther2, Karin Christenson2, Tudor Oprea3, Anna Karlsson2, Huamei Forsman2, Claes Dahlgren2, Johan Bylund4.   

Abstract

Upon infection with Mycobacterium tuberculosis, neutrophils are massively recruited to the lungs, but the role of these cells in combating the infection is poorly understood. Through a type VII secretion system, M. tuberculosis releases a heterodimeric protein complex, containing a 6-kDa early secreted antigenic target (ESAT-6) and a 10-kDa culture filtrate protein (CFP-10), that is essential for virulence. Whereas the ESAT-6 component possesses multiple virulence-related activities, no direct biological activity of CFP-10 has been shown, and CFP-10 has been described as a chaperone protein for ESAT-6. We here show that the ESAT-6:CFP-10 complex induces a transient release of Ca(2+) from intracellular stores in human neutrophils. Surprisingly, CFP-10 rather than ESAT-6 was responsible for triggering the Ca(2+) response, in a pertussis toxin-sensitive manner, suggesting the involvement of a G-protein-coupled receptor. In line with this, the response was accompanied by neutrophil chemotaxis and activation of the superoxide-producing NADPH-oxidase. Neutrophils were unique among leukocytes in responding to CFP-10, as monocytes and lymphocytes failed to produce a Ca(2+) signal upon stimulation with the M. tuberculosis protein. Hence, CFP-10 may contribute specifically to neutrophil recruitment and activation during M. tuberculosis infection, representing a novel biological role for CFP-10 in the ESAT-6:CFP-10 complex, beyond the previously described chaperone function.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25332123      PMCID: PMC4288871          DOI: 10.1128/IAI.02493-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  A novel receptor cross-talk between the ATP receptor P2Y2 and formyl peptide receptors reactivates desensitized neutrophils to produce superoxide.

Authors:  Karin Önnheim; Karin Christenson; Michael Gabl; Joachim C Burbiel; Christa E Müller; Tudor I Oprea; Johan Bylund; Claes Dahlgren; Huamei Forsman
Journal:  Exp Cell Res       Date:  2014-02-01       Impact factor: 3.905

2.  Mycobacterium tuberculosis 19-kDa lipoprotein promotes neutrophil activation.

Authors:  C Neufert; R K Pai; E H Noss; M Berger; W H Boom; C V Harding
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

3.  Granule exocytosis contributes to priming and activation of the human neutrophil respiratory burst.

Authors:  Silvia M Uriarte; Madhavi J Rane; Gregory C Luerman; Michelle T Barati; Richard A Ward; William M Nauseef; Kenneth R McLeish
Journal:  J Immunol       Date:  2011-06-03       Impact factor: 5.422

4.  N-formyl peptide receptor 3 (FPR3) departs from the homologous FPR2/ALX receptor with regard to the major processes governing chemoattractant receptor regulation, expression at the cell surface, and phosphorylation.

Authors:  Marie-Josèphe Rabiet; Laurence Macari; Claes Dahlgren; François Boulay
Journal:  J Biol Chem       Date:  2011-05-04       Impact factor: 5.157

5.  Priming of human neutrophils by mycobacterial lipoarabinomannans: role of granule mobilisation.

Authors:  J Fäldt; C Dahlgren; M Ridell; A Karlsson
Journal:  Microbes Infect       Date:  2001-11       Impact factor: 2.700

6.  The FPR2-induced rise in cytosolic calcium in human neutrophils relies on an emptying of intracellular calcium stores and is inhibited by a gelsolin-derived PIP2-binding peptide.

Authors:  Huamei Forsman; Claes Dahlgren
Journal:  BMC Cell Biol       Date:  2010-07-06       Impact factor: 4.241

Review 7.  Neutrophils in tuberculosis: friend or foe?

Authors:  David M Lowe; Paul S Redford; Robert J Wilkinson; Anne O'Garra; Adrian R Martineau
Journal:  Trends Immunol       Date:  2011-11-15       Impact factor: 16.687

8.  Human macrophages infected with a high burden of ESAT-6-expressing M. tuberculosis undergo caspase-1- and cathepsin B-independent necrosis.

Authors:  Amanda Welin; Daniel Eklund; Olle Stendahl; Maria Lerm
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

9.  Induction of M3-restricted cytotoxic T lymphocyte responses by N-formylated peptides derived from Mycobacterium tuberculosis.

Authors:  T Chun; N V Serbina; D Nolt; B Wang; N M Chiu; J L Flynn; C R Wang
Journal:  J Exp Med       Date:  2001-05-21       Impact factor: 14.307

Review 10.  The spectrum of latent tuberculosis: rethinking the biology and intervention strategies.

Authors:  Clifton E Barry; Helena I Boshoff; Véronique Dartois; Thomas Dick; Sabine Ehrt; JoAnne Flynn; Dirk Schnappinger; Robert J Wilkinson; Douglas Young
Journal:  Nat Rev Microbiol       Date:  2009-10-26       Impact factor: 60.633

View more
  9 in total

1.  Bacterial Strain-Dependent Dissociation of Cell Recruitment and Cell-to-Cell Spread in Early M. tuberculosis Infection.

Authors:  B Shoshana Zha; Ludovic Desvignes; Tawania J Fergus; Amber Cornelius; Tan-Yun Cheng; D Branch Moody; Joel D Ernst
Journal:  mBio       Date:  2022-06-13       Impact factor: 7.786

2.  The Neutrophil Response Induced by an Agonist for Free Fatty Acid Receptor 2 (GPR43) Is Primed by Tumor Necrosis Factor Alpha and by Receptor Uncoupling from the Cytoskeleton but Attenuated by Tissue Recruitment.

Authors:  Lena Björkman; Jonas Mårtensson; Malene Winther; Michael Gabl; André Holdfeldt; Martin Uhrbom; Johan Bylund; Anders Højgaard Hansen; Sunil K Pandey; Trond Ulven; Huamei Forsman; Claes Dahlgren
Journal:  Mol Cell Biol       Date:  2016-09-26       Impact factor: 4.272

3.  Staphylococcal superantigen-like protein 13 activates neutrophils via formyl peptide receptor 2.

Authors:  Yuxi Zhao; Kok P M van Kessel; Carla J C de Haas; Malbert R C Rogers; Jos A G van Strijp; Pieter-Jan A Haas
Journal:  Cell Microbiol       Date:  2018-09-17       Impact factor: 3.715

4.  Tuberculosis diagnosis: algorithm that May discriminate latent from active tuberculosis.

Authors:  Elvis Ndukong Ndzi; Celine Nguefeu Nkenfou; Eric Walter Yone Pefura; Linda Chapdeleine Mouafo Mekue; Elise Guiedem; Carine Nkenfou Nguefeu; Marie Nicole Ngoufack; Elise Elong; Laeticia Grace Yatchou; Alexis Ndjolo; Jules-Roger Kuiate
Journal:  Heliyon       Date:  2019-10-18

5.  Porphyromonas gingivalis Produce Neutrophil Specific Chemoattractants Including Short Chain Fatty Acids.

Authors:  Agnes Dahlstrand Rudin; Arsham Khamzeh; Vignesh Venkatakrishnan; Tishana Persson; Michael Gabl; Otto Savolainen; Huamei Forsman; Claes Dahlgren; Karin Christenson; Johan Bylund
Journal:  Front Cell Infect Microbiol       Date:  2021-01-19       Impact factor: 5.293

Review 6.  Recent applications and strategies in nanotechnology for lung diseases.

Authors:  Wenhao Zhong; Xinyu Zhang; Yunxin Zeng; Dongjun Lin; Jun Wu
Journal:  Nano Res       Date:  2021-01-08       Impact factor: 8.897

7.  EsxA membrane-permeabilizing activity plays a key role in mycobacterial cytosolic translocation and virulence: effects of single-residue mutations at glutamine 5.

Authors:  Qi Zhang; Decheng Wang; Guozhong Jiang; Wei Liu; Qing Deng; Xiujun Li; Wei Qian; Hugues Ouellet; Jianjun Sun
Journal:  Sci Rep       Date:  2016-09-07       Impact factor: 4.379

8.  Surface Enhanced CdSe/ZnS QD/SiNP Electrochemical Immunosensor for the Detection of Mycobacterium Tuberculosis by Combination of CFP10-ESAT6 for Better Diagnostic Specificity.

Authors:  Noremylia Mohd Bakhori; Nor Azah Yusof; Jaafar Abdullah; Helmi Wasoh; Siti Khadijah Ab Rahman; Siti Fatimah Abd Rahman
Journal:  Materials (Basel)       Date:  2019-12-31       Impact factor: 3.623

Review 9.  A Small Protein but with Diverse Roles: A Review of EsxA in Mycobacterium-Host Interaction.

Authors:  Yanqing Bao; Lin Wang; Jianjun Sun
Journal:  Cells       Date:  2021-06-30       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.